Date: Friday 26 Apr 2013
A round-up of the biggest director buys today so far.
Date: Friday 19 Apr 2013
A round-up of the biggest director deals today so far.
Date: Monday 04 Feb 2013
AIM-listed pharmaceuticals company Vernalis has received a 1.5m dollar payment under its drug discovery collaboration with Genentech, a member of the Roche group.
| Currency | UK Pounds |
| Share Price | 22.50p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 27.38 |
| 52 Week Low | 21.63 |
| Volume | 0 |
| Shares Issued | 442.11m |
| Market Cap | £99.48m |
| Beta | 0.16 |
| RiskGrade | 62 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| No dividends found |
You are here: research